BUY Piramal Pharma Limited — Siddharth Rai Mangala
bySiddharth Rai MangalaHorizon: NA (inferred Swing (≤2wk))21 Sept 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·24 Sept · today
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·21 Sept · 3d ago
Piramal Pharma earns ‘Leader’ ESG rating from independent assessor
NewsGoogle News·18 Sept · 5d ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Piramal Pharma
- BUY — Shrikant Chouhan, Kotak Securities9 Nov 2026 · ~1 year · target ₹310 · Active
- BUY — Shrikant Chouhan, Kotak Securities6 Nov 2026 · ~2 weeks · target ₹250 · Target hit
- BUY — Amol Athawale, Kotak Securities4 Nov 2026 · ~3 months · target ₹270 · Active
- BUY — Rakesh Bansal2 Nov 2026 · ~2 weeks · target ₹267 · Active
- BUY — Kunal Saraogi30 Oct 2026 · ~1 year · target ₹300 · Active
More from Siddharth Rai Mangala
- BUY Anand Rathi Wealth13 Nov 2026 · ~1 year · target ₹2,440 · Active
- BUY FSN E-Commerce Ventures13 Nov 2026 · ~2 weeks · target ₹385 · Active
- BUY Premier Energies13 Nov 2026 · ~1 year · target ₹930 · Active
- BUY Max Healthcare Institute13 Nov 2026 · ~2 weeks · target ₹975 · Active
- BUY V2 Retail12 Nov 2026 · ~1 year · target ₹280 · Active

